The Evil Dex.Kevin Drum

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

Hell, all they had to do was ask me:

Scientists at the University of Oxford said on Tuesday that they have identified what they called the first drug proven to reduce coronavirus-related deaths, after a 6,000-patient trial of the drug in Britain showed that a low-cost steroid could reduce deaths significantly for hospitalized patients. The steroid, dexamethasone, reduced deaths by a third in patients receiving ventilation, and by a fifth in patients receiving only oxygen treatment, the scientists said. They found no benefit from the drug in patients who did not need respiratory support.

The Evil Dex! The four-dollar pill that does everything! But this is only fair. My immunocompromised status makes me more likely to be hospitalized from COVID-19, but my long-time status as a dex user will help me survive. Funny how that works.

In related news, my doctor has approved a reduction in my dex intake to 2 mg. This is such a tiny dose it’s surprising my body will even know it’s there. Then again, my body has gotten increasingly sensitive to it over the years, so maybe all I need to do is wave a pill in front of my nose and that would be enough. Future M-protein tests will tell us whether 2 mg works.

UPDATE: Since I spend a lot of time griping about the side effects of dex, I should mention that they only appear after several weeks on the stuff. My guess is that patients with COVID-19 who are given dex for a week or two won’t suffer much in the way of side effects at all.

UPDATE 2: Via Twitter, Craig Kaplan writes: “Important to be very clear about Dex use as something that can only treat haywire immune response to coronavirus infection but likely would increase chance of infection if taken early. Timing will be everything and only should be given later in disease course to mitigate.”

In other words, don’t even think about taking dex if you aren’t in the hospital, hoping that it might protect you from COVID-19. It won’t, and it might even make things worse. It only works among hospitalized patients who are on oxygen treatment.

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate